Non-human primate models for disease and human biology: The impact of the Major Histocompatibility Complex

Q3 Pharmacology, Toxicology and Pharmaceutics Drug Discovery Today: Disease Models Pub Date : 2017-03-01 DOI:10.1016/j.ddmod.2017.11.003
Gaby G.M. Doxiadis, Ronald E. Bontrop
{"title":"Non-human primate models for disease and human biology: The impact of the Major Histocompatibility Complex","authors":"Gaby G.M. Doxiadis,&nbsp;Ronald E. Bontrop","doi":"10.1016/j.ddmod.2017.11.003","DOIUrl":null,"url":null,"abstract":"<div><p><span>MHC class I and II molecules play an important role in the adaptive immune response. The genes encoding the MHC molecules are highly polymorphic, thus enabling each molecule to bind a unique repertoire of peptides, which are then presented to </span>T cells<span><span><span>, and may induce an immune reaction. MHC class I and II alleles of non-human primates (NHP) have been shown to influence the susceptibility or resistance to various diseases: for example, autoimmune diseases like rheumatoid arthritis and </span>multiple sclerosis. Thus, knowledge of the susceptibility and/or resistance markers is of value for studying these diseases in experimental settings. Furthermore, in AIDS research, HLA class I molecules of human elite controllers have been shown to share a similar peptide binding motif, like the </span>rhesus macaque<span> class I molecules that are linked to elite control. This finding suggests that immunodominant epitopes of MHC molecules associated with SIV control may also be significant in human HIV control. Thus, macaques have been proven to be an excellent model for HIV/SIV research.</span></span></p></div>","PeriodicalId":39774,"journal":{"name":"Drug Discovery Today: Disease Models","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2017-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ddmod.2017.11.003","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug Discovery Today: Disease Models","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1740675717300282","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0

Abstract

MHC class I and II molecules play an important role in the adaptive immune response. The genes encoding the MHC molecules are highly polymorphic, thus enabling each molecule to bind a unique repertoire of peptides, which are then presented to T cells, and may induce an immune reaction. MHC class I and II alleles of non-human primates (NHP) have been shown to influence the susceptibility or resistance to various diseases: for example, autoimmune diseases like rheumatoid arthritis and multiple sclerosis. Thus, knowledge of the susceptibility and/or resistance markers is of value for studying these diseases in experimental settings. Furthermore, in AIDS research, HLA class I molecules of human elite controllers have been shown to share a similar peptide binding motif, like the rhesus macaque class I molecules that are linked to elite control. This finding suggests that immunodominant epitopes of MHC molecules associated with SIV control may also be significant in human HIV control. Thus, macaques have been proven to be an excellent model for HIV/SIV research.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
疾病和人类生物学的非人类灵长类动物模型:主要组织相容性复合体的影响
MHC I类和II类分子在适应性免疫应答中起重要作用。编码MHC分子的基因是高度多态性的,因此使每个分子能够结合独特的肽库,然后将其呈现给T细胞,并可能诱导免疫反应。非人类灵长类动物(NHP)的MHC I类和II类等位基因已被证明影响对各种疾病的易感性或抵抗力:例如,类风湿性关节炎和多发性硬化症等自身免疫性疾病。因此,了解易感性和/或抗性标记对于在实验环境中研究这些疾病是有价值的。此外,在艾滋病研究中,人类精英控制者的HLA I类分子已被证明具有相似的肽结合基序,就像恒河猴精英控制者的I类分子一样。这一发现表明,与SIV控制相关的MHC分子的免疫显性表位也可能在人类HIV控制中具有重要意义。因此,猕猴已被证明是HIV/SIV研究的优秀模型。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Drug Discovery Today: Disease Models
Drug Discovery Today: Disease Models Pharmacology, Toxicology and Pharmaceutics-Drug Discovery
自引率
0.00%
发文量
0
期刊介绍: Drug Discovery Today: Disease Models discusses the non-human experimental models through which inference is drawn regarding the molecular aetiology and pathogenesis of human disease. It provides critical analysis and evaluation of which models can genuinely inform the research community about the direct process of human disease, those which may have value in basic toxicology, and those which are simply designed for effective expression and raw characterisation.
期刊最新文献
Balanced actions of estradiol and progesterone—A new paradigm of women’s reproductive health Women’s reproductive system as balanced estradiol and progesterone actions—A revolutionary, paradigm-shifting concept in women’s health Influence of progestagens on bone health. Bone changes related to ovulatory disturbances and low progesterone levels Hereditary bullous diseases: current and innovative models to study the skin blistering disease epidermolysis bullosa The extent and causes of natural variation in menstrual cycles: Integrating empirically-based models of ovarian cycling into research on women’s health
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1